Harding Susan M
Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, 1900 University Blvd, THT Rm 215, Birmingham, AL 35294, USA.
Immunol Allergy Clin North Am. 2005 Feb;25(1):131-48. doi: 10.1016/j.iac.2004.09.006.
Gastroesophageal reflux (GER) is a potential trigger of asthma. Approximately 77% of asthmatics report heartburn. GER is a risk factor for asthma-related hospitalization and oral steroid burst use. Asthmatics may be predisposed to GER development because of a high prevalence of hiatal hernia and autonomic dysregulation and an increased pressure gradient between the abdominal cavity and the thorax, over-riding the lower esophageal sphincter pressure barrier. Asthma medications may potentiate GER. Potential mechanisms of esophageal acid-induced bronchoconstriction include a vagally mediated reflex, local axonal reflexes, heightened bronchial reactivity, and microaspiration, all resulting in neurogenic inflammation. Anti-reflux therapy improves asthma symptoms in approximately 70% of asthmatics with GER. A 3-month empiric trial of twice-daily proton pump inhibitor given 30 to 60 minutes before breakfast and dinner can identify asthmatics who have GER as a trigger of their asthma.
胃食管反流(GER)是哮喘的一个潜在触发因素。约77%的哮喘患者报告有烧心症状。GER是哮喘相关住院和口服类固醇冲击治疗的一个危险因素。由于食管裂孔疝和自主神经调节异常的高患病率以及腹腔与胸腔之间压力梯度增加,超过了食管下括约肌压力屏障,哮喘患者可能易发生GER。哮喘药物可能会增强GER。食管酸诱导支气管收缩的潜在机制包括迷走神经介导的反射、局部轴突反射、支气管反应性增强和微误吸,所有这些都会导致神经源性炎症。抗反流治疗可改善约70%有GER的哮喘患者的哮喘症状。在早餐和晚餐前30至60分钟每天两次给予质子泵抑制剂进行为期3个月的经验性试验,可识别出GER作为哮喘触发因素的哮喘患者。